These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 5125054

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Nil nocere. Adverse effects of amantadine therapy of parkinsonism. Summary to E.W. Fünfgeld: "Long-time therapy of parkinsonism with amantadine sulfate" and to G. Völler: "Amantadine therapy of parkinsonism"].
    Diehl LW.
    Munch Med Wochenschr; 1972 Jun 02; 114(22):1068. PubMed ID: 5068023
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Parkinsonism].
    Kaumeier S.
    Fortschr Med; 1978 Jul 27; 96(28):1397-404. PubMed ID: 27434
    [No Abstract] [Full Text] [Related]

  • 29. [Correlation of clinico-physiologic indices and the serotonin content of the blood of patients with parkinsonism].
    Karimova MKh, Petelin LS, Aleuov ShA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988 Jul 27; 88(10):50-2. PubMed ID: 3213330
    [Abstract] [Full Text] [Related]

  • 30. [Preliminary results of the use of amantadine in parkinsonian syndromes].
    Montanari M, Monaco V, Robotti CA.
    Minerva Med; 1971 Oct 31; 62(82):3955-7. PubMed ID: 5125050
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
    Ambrosetto C, Martinelli P.
    Minerva Med; 1971 Oct 31; 62(82):4017-9. PubMed ID: 5125069
    [No Abstract] [Full Text] [Related]

  • 32. Clinical evaluation of biperiden in Parkinson's disease.
    Strang RR.
    Dis Nerv Syst; 1967 Mar 31; 28(3):191-3. PubMed ID: 5335879
    [No Abstract] [Full Text] [Related]

  • 33. A double-blind evaluation of S.D. 25 in the treatment of Parkinson's disease.
    Strang RR.
    Curr Med Drugs; 1966 Dec 31; 7(4):20-6. PubMed ID: 5976205
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Data on the therapeutic action of amantadine in parkinsonian syndromes].
    Barone A, Gentile A, Scoleri G.
    Minerva Med; 1971 Oct 31; 62(82):3979-83. PubMed ID: 5125058
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Therapeutic effects of amantadine hydrochloride on manifestations of parkinsonism].
    Espadaler Medina JM, Olivella Rius J, Ruscadella Nadal J.
    Rev Esp Otoneurooftalmol Neurocir; 1971 Oct 31; 28(164):236-46. PubMed ID: 5398580
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.